Arcturus Therapeutics
ARCT
ARCT
165 hedge funds and large institutions have $820M invested in Arcturus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 52 increasing their positions, 55 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
1% less call options, than puts
Call options by funds: $9.75M | Put options by funds: $9.89M
5% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 55
Holders
165
Holding in Top 10
–
Calls
$9.75M
Puts
$9.89M
Top Buyers
| 1 | +$18.6M | |
| 2 | +$9.28M | |
| 3 | +$8.22M | |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$6.53M |
| 5 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$5.28M |
Top Sellers
| 1 | -$10M | |
| 2 | -$5.35M | |
| 3 | -$4.65M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$4.12M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$3.79M |